The pronounced high expression of discoidin domain receptor 2 in human interstitial lung diseases

Huan Bian, Xiaowei Nie, Xin Bu, Feng Tian, Libo Yao, Jingyu Chen, Jin Su

Source: ERJ Open Res, 4 (1) 00138-2016; 10.1183/23120541.00138-2016
Journal Issue: January
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Huan Bian, Xiaowei Nie, Xin Bu, Feng Tian, Libo Yao, Jingyu Chen, Jin Su. The pronounced high expression of discoidin domain receptor 2 in human interstitial lung diseases. ERJ Open Res, 4 (1) 00138-2016; 10.1183/23120541.00138-2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation
Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis
Year: 2006


αVβ6 integrin expression in interstitial lung diseases
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009


Expression of discoidin domain receptor 1 tyrosine kinase on the human bronchial epithelium
Source: Eur Respir J 2001; 17: 969-974
Year: 2001



Increased intraalveolar level of soluble endothelial protein C receptor in patients with interstitial lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 319s
Year: 2004

Resistance of BAL immune cells to apoptosis in interstitial lung diseases (ILD) with high local tumor necrosis factor-α (TNFα) levels as a possible consequence of common TNF receptor type 2 expression
Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease
Year: 2008


Elevated serum B cell activating factor belonging to the TNF family (BAFF) in interstitial lung diseases associated with collagen vascular disease
Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease
Year: 2012

Expression and functional involvement of muscarinic receptor 3 (M3) in human lung fibroblasts in COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 121s
Year: 2005

Enhanced expression of Fas ligand (FasL) in fibrotic interstitial lung diseases (ILDs). The possible role of membrane-bound FasL form
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011


Differential expression of stromal cell derived factor-1/CXC chemokine receptor 4 (SDF-1/CXCL12 – CXCR4) biological axis between idiopathic pulmonary fibrosis and interstitial pneumonia associated with collagen vascular disease: a bronchoalveolar la
Source: Annual Congress 2008 - Interstitial lung disease in systemic and vascular disorders
Year: 2008

Differential expression and regulation of toll-like receptors 1-9 in human airway epithelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 19s
Year: 2001

Activation of discoidin domain receptor 1 on CD14 positive bronchoalveolar lavage fluid cells induces chemokine production in idiopathic pulmonary fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 675s
Year: 2006

TGF-β receptor expression determines progressive fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 461s
Year: 2005

Increased toll-like receptor 4 expression in mice lung tissue under intermittent hypoxia
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012

Expression profiles of inhibitory of growth family member 4 (ING4) in different forms of pulmonary fibrosis
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Calcium-sensing receptor (CaSR) drives lung ECM remodelling and fibrosis in murine asthma models and in ageing mice
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019


Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015



Loss of polymeric immunoglobulin receptor expression is associated with lung tumourigenesis
Source: Eur Respir J 2012; 39: 1171-1180
Year: 2012



CXCR1 and CXCR2 haplotypes synergistically modulate cystic fibrosis lung disease
Source: Eur Respir J 2012; 39: 1385-1390
Year: 2012



Simultaneous mRNA expression analysis of transforming growth factor β1 and three types of TGF-β receptors in broncho-alveolar lavage cells from patients with interstitial lung diseases – the pilot study
Source: Eur Respir J 2003; 22: Suppl. 45, 223s
Year: 2003

Imbalanced expression of the type I TGF-beta receptors ALK-1 in pulmonary fibrosis
Source: Annual Congress 2009 - Mechanisms of pulmonary inflammation and fibrosis
Year: 2009